この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2002/10/241 分で読めます
Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEPREX; Amendment
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending a previous determination of the regulatory review period for MIFEPREX that appeared in the Federal Register of January 25, 2002 (67 FR 3724). The agency is taking this action in response to received comments. FDA is publishing notice of that amendment as required by law.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →